Created by W.Langdon from gp-bibliography.bib Revision:1.8098
The next section will introduce genetic programming, including a very short over view of the many areas where GP has been applied, before Section 4 concentrates on uses of genetic programming in the Pharmaceutical industry. We finish with a worked example (Section 5) which describes an evaluation of machine learning for predicting potential drugs' activity with an pharmaceutically important enzyme (Human cytochrome P450 2D6) made by GlaxoSmithKline chemists \cite{langdon:2001:wsc6}, \cite{langdon:2002:EuroGP}, \cite{langdon:2002:kdmdd}, \cite{langdon:2002:iberamia}, \cite{his02Plenary:Langdon}, \cite{langdon:2003:CEC}. Appendix A gives pointers to further information.",
Genetic Programming entries for William B Langdon